查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1453970

到 2030 年重建皮膚模型的全球市場預測：按類型、應用、最終用戶和地區進行分析

Reconstructed Skin Models Market Forecasts to 2030 - Global Analysis By Type, By Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球重建皮膚模型市場規模為 3,740 萬美元，預計到 2030 年將達到 9,970 萬美元，預測期內年複合成長率為 15.0%。

重建皮膚模型是實驗室製造的結構，模仿人類皮膚的特性和功能。這些模型通常由生長在支架或基質上的細胞層組成，複製表皮、真皮，有時會複製皮下層。它用於製藥、化妝品和醫學研究，以研究皮膚生理學、毒性測試以及護膚產品和治療方法的有效性。

根據美國皮膚病學會2022年發布的統計數據，美國每天約有9500人被診斷出患有皮膚癌。

對動物試驗替代品的需求不斷成長

重建皮膚模型提供了一種人道且符合道德的測試方法，取代了動物測試的需要。此外，它密切模仿人體皮膚生理和對各種物質的反應，從而產生更準確和可靠的結果。隨著對動物測試的監管更加嚴格以及動物福利意識的提高，重建皮膚模型的採用預計將顯著增加。

開發和檢驗成本高

創建準確可靠的皮膚模型需要先進的實驗室設施、專業設備和熟練的人員，並且需要大量的投資。此外，進行嚴格的檢驗研究以確保模型準確地再現人類皮膚生理學也會增加成本。這些成本對於小型研究機構和公司來說是昂貴的，並且可能限制重建皮膚模型的開發和採用。此外，漫長而複雜的檢驗過程可能會延遲新模型的商業化，並阻礙其普及和市場成長。

組織工程技術進步

細胞培養技術、生物材料和 3D 列印技術的創新使得更複雜和生理相關的皮膚模型的開發成為可能。這些進步使研究人員能夠創建具有更高準確性、功能性和可重複性的模型，以更好地模擬人類皮膚生理學和病理學。此外，自動化和高通量篩檢技術的進步正在促進重建皮膚模型的快速且經濟高效的生產和檢驗，從而推動市場成長。

缺乏標準化

缺乏普遍接受的模型開發、檢驗和使用通訊協定和指南，導致實驗室和研究之間的模型品質、性能和再現性存在差異。這種差異破壞了研究結果的可靠性和可比性，並阻礙了皮膚重建模型在監管測試和工業應用中的採用。此外，如果沒有標準化的方法，就存在資料不一致和誤解的風險，從而在相關人員中造成不確定性和懷疑。

COVID-19 的影響：

COVID-19 大流行擾亂了研究活動和供應鏈，從而影響了重建皮膚模型市場。實驗室關閉、旅行限制和社交距離措施導致模型開發和檢驗研究的延遲。此外，分配給非新冠病毒相關研究的資金和資源減少進一步減緩了市場進展。然而，這種流行病也凸顯了替代測試方法的重要性，這可能會推動未來對重建皮膚模型的需求。

預計預測期內化妝品檢測領域規模最大

由於動物測試法規的不斷加強以及消費者對無殘忍和安全化妝品的需求不斷成長，預計化妝品測試行業將在預測期內引領皮膚重建模型市場。重建皮膚模型提供了一種可靠的替代方案來評估化妝品的安全性、功效和毒性，而無需進行動物測試。此外，建模技術的進步以及道德和永續實踐意識的提高進一步支持了皮膚重建模型在化妝品測試中的採用。

受託研究機構（CRO）部門預計在預測期內將呈現最高的年複合成長率。

受託研究機構（CRO）部門預計將在預測期內實現重建皮膚模型市場的最高成長率。這一成長是由製藥、化妝品和醫療設備公司擴大將研究和測試活動外包給 CRO 所推動的。這些組織專門從事臨床前研究，包括使用重建皮膚模型進行安全性和功效研究，為產品開發和法規遵循提供經濟高效的解決方案。

比例最高的地區：

在預測期內，由於醫療保健和製藥行業的強勁以及研發活動的頻繁，北美地區預計將引領重建皮膚模型市場。該地區有嚴格的監管標準，推動了對可靠、準確的測試方法（例如重組皮膚模型）的需求。此外，人們越來越認知到化妝品和藥品的道德和有效測試方法的重要性也有助於北美市場的成長。

年複合成長率最高的地區：

預計在預測期內，歐洲重組皮膚模型市場將顯著成長。歐洲擁有完善的製藥和化妝品行業，以及優先考慮安全性和功效測試的嚴格監管標準。此外，不斷增加的研發投資以及人們對重建皮膚模型在道德和準確測試方面的好處的認知不斷提高，正在推動該地區的市場成長。這些因素使歐洲成為重建皮膚模型的主要成長市場。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球重建皮膚模型市場：按類型

  • 表皮皮膚模型
  • 真皮模型
  • 3D重建皮膚模型

第6章全球重建皮膚模型市場：依應用分類

  • 化妝品檢測
    • 皮膚刺激測試
    • 皮膚致敏試驗
  • 化學和毒性測試
  • 其他用途

第7章全球重建皮膚模型市場：依最終用戶分類

  • 合約研究組織（CRO）
  • 化妝品公司
  • 製藥和生物技術公司
  • 研究機構和學術界
  • 其他最終用戶

第8章全球重建皮膚模型市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • AIVITA Biomedical
  • Biopredic International
  • CellSystems
  • CellTechMed GmbH
  • Genoskin
  • LabSkin Creations
  • L'Oreal SA
  • MatTek Corporation
  • OrSkin
  • QGel SA
  • SkinEthic Laboratories
  • StratiCELL
  • Tissue Regeneration Sciences, Inc.
  • VITROCELL Systems GmbH
Product Code: SMRC25522

According to Stratistics MRC, the Global Reconstructed Skin Models Market is accounted for $37.4 million in 2023 and is expected to reach $99.7 million by 2030 growing at a CAGR of 15.0% during the forecast period. Reconstructed skin models are laboratory-produced structures that mimic the properties and functions of human skin. These models typically consist of layers of cells grown on scaffolds or matrices, replicating the epidermis, dermis, and sometimes the subcutaneous layer. They are used in pharmaceutical, cosmetic, and medical research to study skin physiology, toxicity testing, and the efficacy of skincare products and treatments.

According to 2022 statistics published by American Academy of Dermatology, it was reported that approximately 9,500 people are diagnosed with skin cancer every day in the U.S.

Market Dynamics:

Driver:

Growing demand for alternatives to animal testing

Reconstructed skin models offer a humane and ethical approach to testing, replacing the need for animal experimentation. Additionally, they provide more accurate and reliable results, as they closely mimic human skin physiology and response to various substances. With increasing regulatory restrictions on animal testing and rising awareness of animal welfare concerns, the adoption of reconstructed skin models is expected to rise significantly.

Restraint:

High cost of development and validation

Creating accurate and reliable skin models requires sophisticated laboratory facilities, specialized equipment, and skilled personnel, which entail substantial investments. Additionally, conducting rigorous validation studies to ensure the models accurately replicate human skin physiology further adds to the cost. These expenses can be prohibitive for smaller research institutions and companies, limiting their ability to develop and adopt reconstructed skin models. Moreover, the lengthy and complex validation process may delay the commercialization of new models, hindering their widespread adoption and market growth.

Opportunity:

Technological advancements in tissue engineering

Innovations in cell culture techniques, biomaterials, and 3D printing technologies enable the development of more sophisticated and physiologically relevant skin models. These advancements allow researchers to create models with improved accuracy, functionality, and reproducibility, better mimicking human skin physiology and pathology. Additionally, advancements in automation and high-throughput screening techniques facilitate the rapid and cost-effective generation and validation of reconstructed skin models, driving market growth.

Threat:

Lack of standardization

The absence of universally accepted protocols and guidelines for model development, validation, and usage results in variability in model quality, performance, and reproducibility across different laboratories and research studies. This inconsistency undermines the reliability and comparability of research findings, hindering the adoption of reconstructed skin models in regulatory testing and industrial applications. Moreover, without standardized methodologies, there is a risk of data discrepancies and misinterpretation, leading to uncertainty and skepticism among stakeholders.

Covid-19 Impact:

The COVID-19 pandemic has impacted the reconstructed skin models market by disrupting research activities and supply chains. Laboratory closures, travel restrictions, and social distancing measures have led to delays in model development and validation studies. Additionally, reduced funding and resources allocated to non-COVID-related research have further slowed progress in the market. However, the pandemic has also highlighted the importance of alternative testing methods, potentially driving future demand for reconstructed skin models.

The cosmetics testing segment is expected to be the largest during the forecast period

The cosmetics testing segment is projected to lead the reconstructed skin models market during the forecast period due to increasing regulatory restrictions on animal testing and rising consumer demand for cruelty-free and safe cosmetic products. Reconstructed skin models offer a reliable alternative for assessing the safety, efficacy, and toxicity of cosmetics without the need for animal testing. Additionally, advancements in model technology and growing awareness of ethical and sustainable practices further drive the adoption of reconstructed skin models in cosmetics testing.

The contract research organizations (CROs) segment is expected to have the highest CAGR during the forecast period

The contract research organizations (CROs) segment is anticipated to achieve the highest growth rate in the reconstructed skin models market during the forecast period. This growth can be attributed to the increasing outsourcing of research and testing activities by pharmaceutical, cosmetic, and medical device companies to CROs. These organizations specialize in conducting preclinical studies, including safety and efficacy testing using reconstructed skin models, offering cost-effective and efficient solutions for product development and regulatory compliance.

Region with largest share:

During the forecast period, the North American region is poised to lead the reconstructive skin models market owing to its robust healthcare and pharmaceutical industries and high levels of research and development activities. The region has stringent regulatory standards, driving the demand for reliable and accurate testing methods such as reconstructed skin models. Additionally, increasing awareness about the importance of ethical and effective testing methods for cosmetic and pharmaceutical products further contributes to the market's growth in North America.

Region with highest CAGR:

During the forecast period, Europe is expected to experience significant growth in the reconstructive skin models market. Europe boasts a well-established pharmaceutical and cosmetic industry, coupled with stringent regulatory standards that prioritize safety and efficacy testing. Additionally, increasing investments in research and development, along with growing awareness about the benefits of reconstructed skin models for ethical and accurate testing, are driving market growth in the region. These factors position Europe as a key growth market for reconstructive skin models.

Key players in the market

Some of the key players in Reconstructed Skin Models Market include AIVITA Biomedical, Biopredic International, CellSystems, CellTechMed GmbH, Genoskin, LabSkin Creations, L'Oreal S.A. , MatTek Corporation, OrSkin, QGel SA, SkinEthic Laboratories, StratiCELL, Tissue Regeneration Sciences, Inc. and VITROCELL Systems GmbH.

Key Developments:

In June 2023, L'Oreal announced a partnership with the University of California (UC) Berkeley's biotech incubator Bakar Labs. The collaboration opens up avenues for Bakar Labs' incubated startups to benefit from and gain access to L'Oreal's 3D reconstructed skin models, at no cost.

In March 2023, Chanel Research has just made a strategic leap forward to accelerate its knowledge of skin pigment spots, a major aesthetic concern among aging populations, particularly in Asia. In partnership with LabSkin Creations, the luxury giant has successfully used 3D bioprinting techniques to create reconstructed human skin on which a dark spot can appear.

Types Covered:

  • Epidermal Skin Models
  • Dermal Skin Models
  • 3D Reconstructed Skin Models

Applications Covered:

  • Cosmetics Testing
  • Chemicals and Toxicology Testing
  • Other Applications

End Users Covered:

  • Contract Research Organizations (CROs)
  • Cosmetic Companies
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes and Academia
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Reconstructed Skin Models Market, By Type

  • 5.1 Introduction
  • 5.2 Epidermal Skin Models
  • 5.3 Dermal Skin Models
  • 5.4 3D Reconstructed Skin Models

6 Global Reconstructed Skin Models Market, By Application

  • 6.1 Introduction
  • 6.2 Cosmetics Testing
    • 6.2.1 Skin Irritation Test
    • 6.2.2 Skin Sensitization Test
  • 6.3 Chemicals and Toxicology Testing
  • 6.4 Other Applications

7 Global Reconstructed Skin Models Market, By End User

  • 7.1 Introduction
  • 7.2 Contract Research Organizations (CROs)
  • 7.3 Cosmetic Companies
  • 7.4 Pharmaceutical and Biotechnology Companies
  • 7.5 Research Institutes and Academia
  • 7.6 Other End Users

8 Global Reconstructed Skin Models Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 AIVITA Biomedical
  • 10.2 Biopredic International
  • 10.3 CellSystems
  • 10.4 CellTechMed GmbH
  • 10.5 Genoskin
  • 10.6 LabSkin Creations
  • 10.7 L'Oreal S.A.
  • 10.8 MatTek Corporation
  • 10.9 OrSkin
  • 10.10 QGel SA
  • 10.11 SkinEthic Laboratories
  • 10.12 StratiCELL
  • 10.13 Tissue Regeneration Sciences, Inc.
  • 10.14 VITROCELL Systems GmbH

List of Tables

  • Table 1 Global Reconstructed Skin Models Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 4 Global Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 5 Global Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 6 Global Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 7 Global Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 8 Global Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 9 Global Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 10 Global Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 11 Global Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 12 Global Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 13 Global Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 14 Global Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 15 Global Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 16 Global Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 17 Global Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 20 North America Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 21 North America Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 22 North America Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 23 North America Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 24 North America Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 25 North America Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 26 North America Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 27 North America Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 28 North America Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 North America Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 North America Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 31 North America Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 32 North America Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 33 North America Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 34 North America Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 37 Europe Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 38 Europe Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 39 Europe Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 40 Europe Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 Europe Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 42 Europe Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 43 Europe Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 44 Europe Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 45 Europe Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 46 Europe Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 47 Europe Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 48 Europe Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 49 Europe Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 50 Europe Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 51 Europe Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 55 Asia Pacific Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 56 Asia Pacific Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 57 Asia Pacific Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 58 Asia Pacific Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 59 Asia Pacific Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 60 Asia Pacific Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 61 Asia Pacific Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 62 Asia Pacific Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 63 Asia Pacific Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Asia Pacific Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 65 Asia Pacific Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 66 Asia Pacific Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 67 Asia Pacific Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 68 Asia Pacific Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 71 South America Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 72 South America Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 73 South America Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 74 South America Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 75 South America Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 76 South America Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 77 South America Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 78 South America Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 79 South America Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 80 South America Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 81 South America Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 82 South America Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 83 South America Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 84 South America Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 85 South America Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 89 Middle East & Africa Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 90 Middle East & Africa Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 91 Middle East & Africa Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 92 Middle East & Africa Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 93 Middle East & Africa Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 94 Middle East & Africa Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 95 Middle East & Africa Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 96 Middle East & Africa Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 Middle East & Africa Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 98 Middle East & Africa Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 99 Middle East & Africa Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 100 Middle East & Africa Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 101 Middle East & Africa Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 102 Middle East & Africa Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)